CINRYZE with rHuPH20

BIOLOGICAL2 trials

Sponsors

Shire

Conditions

Hereditary AngioedemaHereditary Angioedema (HAE)

Phase 2

A Study to Evaluate the Safety and Pharmacology of Subcutaneous Administration of CINRYZE With Recombinant Human Hyaluronidase

CompletedNCT01426763

ShireHereditary Angioedema

Start: 2011-09-12End: 2011-11-28Updated: 2021-07-19

Subcutaneous CINRYZE With Recombinant Human Hyaluronidase for Prevention of Angioedema Attacks

CompletedNCT01756157

ShireHereditary Angioedema (HAE)

Start: 2013-02-04End: 2013-09-13Updated: 2021-06-03